Atlas Trials

Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)

Clinical trial NCT02466425 · COMPLETED

Trial details

NCT number
NCT02466425
Sponsor
Shire
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder (ADHD)
Start date
2015-06-18
Primary completion
2016-02-16
Enrollment
264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.